These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18783204)

  • 21. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
    Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
    Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.
    Lee T; Robichaud AJ; Boyle KE; Lu Y; Robertson DW; Miller KJ; Fitzgerald LW; McElroy JF; Largent BL
    Bioorg Med Chem Lett; 2003 Feb; 13(4):767-70. PubMed ID: 12639577
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
    Duan X; Zhang M; Zhang X; Wang F; Lei M
    J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational design, synthesis and evaluation of (6aR( *),11bS( *))-1-(4-fluorophenyl)-4-{7-[4-(4-fluorophenyl)-4-oxobutyl]1,2,3,4,6,6a,7,11b,12,12a(RS)-decahydropyrazino[2',1':6,1]pyrido[3,4-b]indol-2-yl}-butan-1-one as a potential neuroleptic agent.
    Chakrabarty R; Rao J; Anand A; Roy AD; Roy R; Shankar G; Dua PR; Saxena AK
    Bioorg Med Chem; 2007 Dec; 15(23):7361-7. PubMed ID: 17869521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
    Brea J; Castro M; Loza MI; Masaguer CF; Raviña E; Dezi C; Pastor M; Sanz F; Cabrero-Castel A; Galán-Rodríguez B; Fernández-Espejo E; Maldonado R; Robledo P
    Neuropharmacology; 2006 Aug; 51(2):251-62. PubMed ID: 16697427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of new biased agonists for the serotonin 5-HT2A receptor: modeling and experimental validation.
    Martí-Solano M; Iglesias A; de Fabritiis G; Sanz F; Brea J; Loza MI; Pastor M; Selent J
    Mol Pharmacol; 2015 Apr; 87(4):740-6. PubMed ID: 25661038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Syntheses and properties of the major hydroxy metabolites in humans of blonanserin AD-5423, a novel antipsychotic agent.
    Ochi T; Sakamoto M; Minamida A; Suzuki K; Ueda T; Une T; Toda H; Matsumoto K; Terauchi Y
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1055-9. PubMed ID: 15686911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
    Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, Synthesis and Biological Investigation of Flavone Derivatives as Potential Multi-Receptor Atypical Antipsychotics.
    Gao L; Yang Z; Xiong J; Hao C; Ma R; Liu X; Liu BF; Jin J; Zhang G; Chen Y
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32911828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the antipsychotic drug pipamperone on the expression of the dopamine D4 receptor.
    Van Craenenbroeck K; Gellynck E; Lintermans B; Leysen JE; Van Tol HH; Haegeman G; Vanhoenacker P
    Life Sci; 2006 Dec; 80(1):74-81. PubMed ID: 16978659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-[(3S)-1-benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: human dopamine D4 ligands with high affinity for the 5-HT2A receptor.
    Arora J; Bordeleau M; Dube L; Jarvie K; Mazzocco L; Peragine J; Tehim A; Egle I
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5253-6. PubMed ID: 16168646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Butyrophenone analogues in the carbazole series: synthesis and determination of affinities at D2 and 5-HT2A receptors.
    Masaguer CF; Formoso E; Raviña E; Tristán H; Loza MI; Rivas E; Fontenla JA
    Bioorg Med Chem Lett; 1998 Dec; 8(24):3571-6. PubMed ID: 9934473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part I: Influence of the substitution on the basic nitrogen and the position of the amide on the affinity for D2L, D4.2, and 5-HT2A receptors.
    Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1565-9. PubMed ID: 17254782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuation of structure-activity relationship study of novel benzamide derivatives as potential antipsychotics.
    Xu M; Guo S; Yang F; Wang Y; Wu C; Jiang X; Zhao Q; Chen W; Tian G; Zhu F; Xie Y; Hu T; Wang Z; He Y; Shen J
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800306. PubMed ID: 30702760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and in vitro binding studies of substituted piperidine naphthamides. Part II: Influence of the substitution on the benzyl moiety on the affinity for D2L, D4.2, and 5-HT2A receptors.
    Carato P; Graulich A; Jensen N; Roth BL; Liégeois JF
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1570-4. PubMed ID: 17251022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictions of binding for dopamine D2 receptor antagonists by the SIE method.
    Wang YT; Su ZY; Hsieh CH; Chen CL
    J Chem Inf Model; 2009 Oct; 49(10):2369-75. PubMed ID: 19769359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel sulfonamides having dual dopamine D2 and D3 receptor affinity show in vivo antipsychotic efficacy with beneficial cognitive and EPS profile.
    Agai-Csongor E; Nógrádi K; Galambos J; Vágó I; Bielik A; Magdó I; Ignácz-Szendrei G; Keseru GM; Greiner I; Laszlovszky I; Schmidt E; Kiss B; Sághy K; Laszy J; Gyertyán I; Zájer-Balázs M; Gémesi L; Domány G
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5340-4. PubMed ID: 17720494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological investigation of tetrahydropyridopyrimidinone derivatives as potential multireceptor atypical antipsychotics.
    Xiamuxi H; Wang Z; Li J; Wang Y; Wu C; Yang F; Jiang X; Liu Y; Zhao Q; Chen W; Zhang J; Xie Y; Hu T; Xu M; Guo S; Akber Aisa H; He Y; Shen J
    Bioorg Med Chem; 2017 Sep; 25(17):4904-4916. PubMed ID: 28774576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis.
    Hamacher A; Weigt M; Wiese M; Hoefgen B; Lehmann J; Kassack MU
    BMC Pharmacol; 2006 Sep; 6():11. PubMed ID: 16978403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.